UNION OF INDIA versus M/S. RANBAXY LABORATORIES LTD. AND OTHERS
Exemption notification dated 29th August, 1995 exempts drugs manufactured up to 31st October, 1999 from price control, and the nexus between manufacture, marketing and sale requires the notification to be construed in a way that allows sale after exemption period if manufacture occurred during the exemption.
- Parties
- Appellant: Union of India; Respondent: M/s. Ranbaxy Laboratories Ltd.
- Jurisdiction
- India
- Judgment Date
- 12 May 2008
- Procedural Posture
- Civil Appeal / Final Judgment on Appeal From Delhi High Court Letters Patent Appeal No. 675 of 2004
- Outcome
- Appeal dismissed with costs.
- Legal Topics
- Interpretation of Exemption Notifications, Drugs (price Control) Order, 1995, Purposive Construction, Essential Commodities Act, 1955
Case Brief
Summary, issues, holding and outcome
More case intelligence is available
Unlock the full research layer for this judgment.
Parties
Union of India
Appellant
M/s. Ranbaxy Laboratories Ltd.
Respondent
Procedural Posture
Civil Appeal / Final Judgment on Appeal From Delhi High Court Letters Patent Appeal No. 675 of 2004
Legal Issues
- 1 Whether the exemption Notification dated 29.8.1995 applies to drugs manufactured up to 31st October, 1999 or both manufactured and sold by that date
- 2 Proper interpretation of exemption notifications under Drugs (Price Control) Order, 1995
Ratio Decidendi
Exemption notification dated 29th August, 1995 exempts drugs manufactured up to 31st October, 1999 from price control, and the nexus between manufacture, marketing and sale requires the notification to be construed in a way that allows sale after exemption period if manufacture occurred during the exemption.
Court Disposition
Appeal dismissed with costs.
Orders
- Appeal dismissed; counsel's fee assessed at Rs.50,000/-
Full Case Text
Judgment text and source record
Sign in to read
Sign in to read the full judgment text
Sign in to read the full judgment text. Downloads and additional research tools may depend on your plan.
Sign in to read the full judgment